vs
RCI HOSPITALITY HOLDINGS, INC.（RICK）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RCI HOSPITALITY HOLDINGS, INC.的季度营收约是RECURSION PHARMACEUTICALS, INC.的2.0倍（$70.9M vs $35.5M），RCI HOSPITALITY HOLDINGS, INC.净利率更高（-7.8% vs -304.2%，领先296.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -2.0%）
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RICK vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $70.9M | $35.5M |
| 净利润 | $-5.5M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -0.7% | -304.8% |
| 净利率 | -7.8% | -304.2% |
| 营收同比 | -3.1% | 681.7% |
| 净利润同比 | -2354.9% | 39.6% |
| 每股收益（稀释后） | $-0.60 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $35.5M | ||
| Q3 25 | $70.9M | $5.2M | ||
| Q2 25 | $71.1M | $19.2M | ||
| Q1 25 | $65.9M | $14.7M | ||
| Q4 24 | $71.5M | $4.5M | ||
| Q3 24 | $73.2M | $26.1M | ||
| Q2 24 | $76.2M | $14.4M | ||
| Q1 24 | $72.3M | $13.8M |
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-5.5M | $-162.3M | ||
| Q2 25 | $4.1M | $-171.9M | ||
| Q1 25 | $3.2M | $-202.5M | ||
| Q4 24 | $9.0M | $-178.9M | ||
| Q3 24 | $244.0K | $-95.8M | ||
| Q2 24 | $-5.2M | $-97.5M | ||
| Q1 24 | $774.0K | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | — | -304.8% | ||
| Q3 25 | -0.7% | -3327.6% | ||
| Q2 25 | 12.2% | -916.8% | ||
| Q1 25 | 12.4% | -1297.9% | ||
| Q4 24 | 19.5% | -4042.4% | ||
| Q3 24 | 4.8% | -377.1% | ||
| Q2 24 | -3.3% | -697.4% | ||
| Q1 24 | 6.4% | -698.4% |
| Q4 25 | — | -304.2% | ||
| Q3 25 | -7.8% | -3135.3% | ||
| Q2 25 | 5.7% | -894.2% | ||
| Q1 25 | 4.9% | -1373.3% | ||
| Q4 24 | 12.6% | -3935.5% | ||
| Q3 24 | 0.3% | -367.5% | ||
| Q2 24 | -6.9% | -676.6% | ||
| Q1 24 | 1.1% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.60 | $-0.36 | ||
| Q2 25 | $0.46 | $-0.41 | ||
| Q1 25 | $0.36 | $-0.50 | ||
| Q4 24 | $1.01 | $-0.56 | ||
| Q3 24 | $0.04 | $-0.34 | ||
| Q2 24 | $-0.56 | $-0.40 | ||
| Q1 24 | $0.08 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.7M | $743.3M |
| 总债务越低越好 | $238.2M | $9.6M |
| 股东权益账面价值 | $261.1M | $1.1B |
| 总资产 | $596.9M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.91× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | $33.7M | $659.8M | ||
| Q2 25 | $29.3M | $525.1M | ||
| Q1 25 | $32.7M | $500.5M | ||
| Q4 24 | $34.7M | $594.4M | ||
| Q3 24 | $32.4M | $427.6M | ||
| Q2 24 | $34.9M | $474.3M | ||
| Q1 24 | $20.0M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $238.2M | $11.9M | ||
| Q2 25 | $243.8M | $14.2M | ||
| Q1 25 | $244.1M | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $241.1M | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | — | $1.1B | ||
| Q3 25 | $261.1M | $1.0B | ||
| Q2 25 | $269.5M | $919.1M | ||
| Q1 25 | $268.8M | $933.9M | ||
| Q4 24 | $269.0M | $1.0B | ||
| Q3 24 | $263.4M | $524.6M | ||
| Q2 24 | $271.2M | $584.4M | ||
| Q1 24 | $285.8M | $401.2M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $596.9M | $1.4B | ||
| Q2 25 | $597.4M | $1.3B | ||
| Q1 25 | $589.8M | $1.3B | ||
| Q4 24 | $586.2M | $1.4B | ||
| Q3 24 | $584.4M | $726.5M | ||
| Q2 24 | $601.0M | $775.9M | ||
| Q1 24 | $609.9M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.91× | 0.01× | ||
| Q2 25 | 0.90× | 0.02× | ||
| Q1 25 | 0.91× | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.92× | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $11.5M | $-47.3M |
| 自由现金流率自由现金流/营收 | 16.2% | -133.1% |
| 资本支出强度资本支出/营收 | 3.2% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $34.9M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $13.7M | $-117.4M | ||
| Q2 25 | $13.8M | $-76.4M | ||
| Q1 25 | $8.5M | $-132.0M | ||
| Q4 24 | $13.3M | $-115.4M | ||
| Q3 24 | $15.7M | $-59.2M | ||
| Q2 24 | $15.8M | $-82.2M | ||
| Q1 24 | $10.8M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | $11.5M | $-117.6M | ||
| Q2 25 | $10.1M | $-79.6M | ||
| Q1 25 | $5.7M | $-133.8M | ||
| Q4 24 | $7.6M | $-116.7M | ||
| Q3 24 | $10.3M | $-63.8M | ||
| Q2 24 | $9.3M | $-83.4M | ||
| Q1 24 | $3.2M | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | 16.2% | -2272.5% | ||
| Q2 25 | 14.2% | -413.9% | ||
| Q1 25 | 8.6% | -907.4% | ||
| Q4 24 | 10.6% | -2567.7% | ||
| Q3 24 | 14.0% | -244.6% | ||
| Q2 24 | 12.3% | -578.5% | ||
| Q1 24 | 4.4% | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | 3.2% | 4.7% | ||
| Q2 25 | 5.2% | 16.4% | ||
| Q1 25 | 4.3% | 12.4% | ||
| Q4 24 | 8.0% | 28.6% | ||
| Q3 24 | 7.3% | 17.5% | ||
| Q2 24 | 8.4% | 8.2% | ||
| Q1 24 | 10.6% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.40× | — | ||
| Q1 25 | 2.65× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 64.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 14.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
RXRX
暂无分部数据
